Premium
Cost‐effectiveness analysis of vaginal misoprostol versus dinoprostone pessary: A non‐inferiority large randomized controlled trial in France
Author(s) -
Mounie Michael,
Costa Nadège,
Gaudineau Adrien,
Molinier Laurent,
Vayssière Christophe,
Derumeaux Hélène
Publication year - 2022
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1002/ijgo.13999
Subject(s) - misoprostol , dinoprostone , medicine , pessary , obstetrics , randomized controlled trial , vaginal delivery , gynecology , pregnancy , surgery , abortion , prostaglandin , genetics , biology
To assess the cost-effectiveness of vaginal misoprostol (PGE1; 25 μg) compared with a slow-release dinoprostone (PGE2) pessary (10 μg) for labor induction due to an unfavorable cervix at term.